GENB
Generate Biomedicines, Inc.
15.20$
-5.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| – | +14.9% | -28.7% | -12.6% | |
| – | – | – | – | |
| – | – | – | +59.8% | |
| – | +27.6% | -8.7% | +17.9% | |
| – | +3.9% | +28.3% | +0.5% | |
| – | +23.4% | -3.2% | +14.5% | |
| – | – | – | – | |
| – | -16.6% | -40.7% | -14.8% | |
| – | – | – | – | |
| – | – | – | +89.3% | |
| – | – | – | – | |
| – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.